Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor with Fludarabine and Cytarabine in Refractory/Relapsed AML
NCT03071276Phase 2Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jan 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in acute myeloid leukemia (AML), sponsored by St. Jude Children's Research Hospital. Started Jan 2016; status: terminated.
02
Drugs
selinexor
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03071276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071276.